Amelioration of murine Schistosoma mansoni induced liver fibrosis by mesenchymal stem cells

M. T. Abdel Aziz, H. M. Atta, N. K. Roshdy, L. A. Rashed, D. Sabry, A. A. Hassouna, G. I. Aboul Fotouh, N. M. Hasan, R. H. Younis, J. R. Chowdhury

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Schistosomiasis is a common chronic helminthic infection of the liver that causes hepatic fibrosis and portal hypertension, contributing to the death of over half a million people a year. Infusion of autologous bone marrow cells into patients with hepatic cirrhosis has been reported to ameliorate symptoms of portal hypertension and improve liver function, either by conversion of the infused mesenchymal stem cells (MSCs) to hepatocytes or by modulating of the hepatic fibrosis. Here, we have investigated the antifibrotic effect of mesenchymal stem cells (MSCs) using S. mansoni-induced liver fibrosis in mice, which causes an intense, stable fibrosis. MSCs derived from bone marrow of male mice were then infused intravenously into female mice that had received intraperitoneal injection of S.mansoni cercariae. Mice were divided into 4 groups: Untreated control; MSCs infusion only; Schistosomiasis only; and Schistosomiasis plus MSCs infusion. Serum alanine aminotransferase (ALT) and liver histopathology were evaluated. Expression of the collagen gene (type I), transforming growth factor (TGF-β), matrix metalloproteinase (MMP2), tissue inhibitor of metalloproteinase (TIMP-1), stromal cell-derived factor-1(SDF-1) and its receptor (CXCR4) were analyzed. MSC infusion resulted in significant decrease in liver collagen and TGF-β gene expression in the Schistosomiasis mice. The ratio of MMP-2 to TIMP-1 expression increased. SDF-1 and CXCR4 mRNA expression also increased. There was overall improvement of liver histology and a statistically significant reduction of serum ALT level. MSCs infusion ameliorated S. mansoni-induced liver fibrosis, probably by modulating the relative expression of MMP and TIMP. The findings support the hypothesis that MSCs participate in liver regeneration and functional improvement by reducing liver fibrosis.

Original languageEnglish (US)
Pages (from-to)P28-P34
JournalJournal of Stem Cells and Regenerative Medicine
Volume8
Issue number1
StatePublished - Jul 11 2012

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Amelioration of murine Schistosoma mansoni induced liver fibrosis by mesenchymal stem cells'. Together they form a unique fingerprint.

  • Cite this

    Abdel Aziz, M. T., Atta, H. M., Roshdy, N. K., Rashed, L. A., Sabry, D., Hassouna, A. A., Aboul Fotouh, G. I., Hasan, N. M., Younis, R. H., & Chowdhury, J. R. (2012). Amelioration of murine Schistosoma mansoni induced liver fibrosis by mesenchymal stem cells. Journal of Stem Cells and Regenerative Medicine, 8(1), P28-P34.